HEADER TRANSFERASE 29-FEB-08 3CEH TITLE HUMAN LIVER GLYCOGEN PHOSPHORYLASE (TENSE STATE) IN COMPLEX WITH THE TITLE 2 ALLOSTERIC INHIBITOR AVE5688 COMPND MOL_ID: 1; COMPND 2 MOLECULE: GLYCOGEN PHOSPHORYLASE, LIVER FORM; COMPND 3 CHAIN: A, B; COMPND 4 EC: 2.4.1.1; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 GENE: PYGL; SOURCE 5 EXPRESSION_SYSTEM: SPODOPTERA FRUGIPERDA; SOURCE 6 EXPRESSION_SYSTEM_COMMON: FALL ARMYWORM; SOURCE 7 EXPRESSION_SYSTEM_CELL_LINE: SF9; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: BACULOVIRUS KEYWDS PROTEIN LIGAND COMPLEX, TENSE STATE, ALLOSTERIC INHIBITOR, ALLOSTERIC KEYWDS 2 ENZYME, CARBOHYDRATE METABOLISM, DISEASE MUTATION, GLYCOGEN KEYWDS 3 METABOLISM, GLYCOGEN STORAGE DISEASE, GLYCOSYLTRANSFERASE, KEYWDS 4 NUCLEOTIDE-BINDING, PHOSPHOPROTEIN, PYRIDOXAL PHOSPHATE, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR K.U.WENDT,M.K.DREYER,O.ANDERKA,T.KLABUNDE,P.LOENZE,E.DEFOSSA, AUTHOR 2 D.SCHMOLL REVDAT 5 29-JUL-20 3CEH 1 COMPND REMARK HETNAM LINK REVDAT 5 2 1 SITE REVDAT 4 13-JUL-11 3CEH 1 VERSN REVDAT 3 24-FEB-09 3CEH 1 VERSN REVDAT 2 03-JUN-08 3CEH 1 JRNL REVDAT 1 27-MAY-08 3CEH 0 JRNL AUTH O.ANDERKA,P.LOENZE,T.KLABUNDE,M.K.DREYER,E.DEFOSSA, JRNL AUTH 2 K.U.WENDT,D.SCHMOLL JRNL TITL THERMODYNAMIC CHARACTERIZATION OF ALLOSTERIC GLYCOGEN JRNL TITL 2 PHOSPHORYLASE INHIBITORS. JRNL REF BIOCHEMISTRY V. 47 4683 2008 JRNL REFN ISSN 0006-2960 JRNL PMID 18373353 JRNL DOI 10.1021/BI702397D REMARK 2 REMARK 2 RESOLUTION. 2.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 43.60 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 3 NUMBER OF REFLECTIONS : 51525 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.170 REMARK 3 R VALUE (WORKING SET) : 0.165 REMARK 3 FREE R VALUE : 0.247 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 2618 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.80 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.87 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3620 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.02 REMARK 3 BIN R VALUE (WORKING SET) : 0.2440 REMARK 3 BIN FREE R VALUE SET COUNT : 204 REMARK 3 BIN FREE R VALUE : 0.3280 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 12898 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 142 REMARK 3 SOLVENT ATOMS : 508 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 35.76 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.00000 REMARK 3 B22 (A**2) : 0.00000 REMARK 3 B33 (A**2) : 0.01000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): 0.373 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.269 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 13.906 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.944 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.877 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 13375 ; 0.014 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 18108 ; 1.599 ; 1.968 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 1590 ; 6.800 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 648 ;37.826 ;24.275 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 2376 ;19.033 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 80 ;16.734 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 1969 ; 0.109 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 10112 ; 0.005 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 7080 ; 0.235 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 9117 ; 0.322 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 777 ; 0.175 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 58 ; 0.252 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 10 ; 0.224 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 8140 ; 0.679 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 12846 ; 1.173 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 5973 ; 1.630 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 5262 ; 2.680 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : BABINET MODEL WITH MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3CEH COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 11-MAR-08. REMARK 100 THE DEPOSITION ID IS D_1000046677. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NULL REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 6.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : NULL REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : NULL REMARK 200 DETECTOR MANUFACTURER : NULL REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 51974 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.800 REMARK 200 RESOLUTION RANGE LOW (A) : 43.600 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: NULL REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 57.97 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.93 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 7 MG/ML IN 20 MM BES, 1 MM EDTA, 0.5 REMARK 280 MM DTT, PH 6.5, 50 MM NBG, 2.5 MM AVE5688, VAPOR DIFFUSION, REMARK 280 HANGING DROP REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 31 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+1/3 REMARK 290 3555 -X+Y,-X,Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 40.83033 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 81.66067 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 7690 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 56370 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -25.5 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 ASN A 253 REMARK 465 LEU A 254 REMARK 465 ARG A 255 REMARK 465 ASP A 256 REMARK 465 PHE A 257 REMARK 465 ASN A 258 REMARK 465 VAL A 259 REMARK 465 GLY A 260 REMARK 465 GLY A 317 REMARK 465 SER A 318 REMARK 465 THR A 319 REMARK 465 ARG A 320 REMARK 465 GLY A 321 REMARK 465 ALA A 322 REMARK 465 GLY A 323 REMARK 465 ASN B 253 REMARK 465 LEU B 254 REMARK 465 ARG B 255 REMARK 465 ASP B 256 REMARK 465 PHE B 257 REMARK 465 ASN B 258 REMARK 465 VAL B 259 REMARK 465 GLY B 260 REMARK 465 GLY B 317 REMARK 465 SER B 318 REMARK 465 THR B 319 REMARK 465 ARG B 320 REMARK 465 GLY B 321 REMARK 465 ALA B 322 REMARK 465 GLY B 323 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OD2 ASP A 128 OG SER A 651 2.12 REMARK 500 ND2 ASN B 274 NH1 ARG B 277 2.13 REMARK 500 ND2 ASN A 274 NH1 ARG A 277 2.15 REMARK 500 NZ LYS A 680 O4A PLP A 832 2.15 REMARK 500 N THR A 324 O HOH A 995 2.17 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU B 384 CA - CB - CG ANGL. DEV. = 17.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 76 -79.52 -76.13 REMARK 500 LEU A 131 50.43 -99.19 REMARK 500 TYR A 203 -141.56 62.13 REMARK 500 ASP A 217 53.86 37.96 REMARK 500 ASN A 235 -158.76 -128.16 REMARK 500 ASN A 250 -77.95 15.89 REMARK 500 LYS A 315 49.87 -106.74 REMARK 500 ASN A 338 96.05 -68.20 REMARK 500 ASP A 339 -159.88 56.00 REMARK 500 LEU A 344 -16.18 -49.59 REMARK 500 LYS A 358 12.98 58.32 REMARK 500 HIS A 410 -74.12 -49.34 REMARK 500 ARG A 413 0.25 -69.99 REMARK 500 LYS A 466 -75.46 -106.02 REMARK 500 ARG A 489 -73.04 -86.79 REMARK 500 LEU A 492 -74.54 -128.11 REMARK 500 GLU A 552 -73.35 -99.70 REMARK 500 VAL A 555 129.75 -175.50 REMARK 500 LYS A 568 164.19 166.12 REMARK 500 THR A 585 -61.89 -28.46 REMARK 500 ASP A 593 68.10 -151.93 REMARK 500 SER A 674 -56.31 -145.07 REMARK 500 GLU A 701 -51.88 -28.50 REMARK 500 LYS A 753 -5.98 -58.26 REMARK 500 GLN A 754 81.83 -157.19 REMARK 500 PRO A 755 10.88 -69.82 REMARK 500 HIS A 768 -15.62 -150.54 REMARK 500 ASP A 769 95.43 -64.04 REMARK 500 PRO A 794 -50.58 -26.90 REMARK 500 ILE A 824 -54.33 -121.13 REMARK 500 PRO A 829 55.96 -59.53 REMARK 500 ASP B 76 -77.31 -56.91 REMARK 500 CYS B 78 56.05 34.84 REMARK 500 LEU B 131 43.34 -92.26 REMARK 500 ASP B 181 43.94 -80.81 REMARK 500 TYR B 203 -139.41 66.92 REMARK 500 HIS B 208 75.02 -105.16 REMARK 500 ASN B 235 -151.79 -133.04 REMARK 500 ASP B 251 106.07 78.99 REMARK 500 SER B 276 34.12 -91.01 REMARK 500 LYS B 315 -62.37 -3.61 REMARK 500 ASP B 339 -170.98 70.10 REMARK 500 PRO B 342 40.98 -90.91 REMARK 500 PRO B 381 -49.59 -28.83 REMARK 500 PHE B 418 58.33 -156.12 REMARK 500 LEU B 425 -72.80 -60.58 REMARK 500 LYS B 437 112.15 78.54 REMARK 500 LYS B 466 -83.66 -109.18 REMARK 500 GLU B 475 75.55 -158.50 REMARK 500 ARG B 489 -76.03 -71.03 REMARK 500 REMARK 500 THIS ENTRY HAS 60 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 PRO A 249 ASN A 250 141.24 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3CEJ RELATED DB: PDB REMARK 900 RELATED ID: 3CEM RELATED DB: PDB DBREF 3CEH A 23 831 UNP P06737 PYGL_HUMAN 24 832 DBREF 3CEH B 23 831 UNP P06737 PYGL_HUMAN 24 832 SEQRES 1 A 809 ASN VAL ALA GLU LEU LYS LYS SER PHE ASN ARG HIS LEU SEQRES 2 A 809 HIS PHE THR LEU VAL LYS ASP ARG ASN VAL ALA THR THR SEQRES 3 A 809 ARG ASP TYR TYR PHE ALA LEU ALA HIS THR VAL ARG ASP SEQRES 4 A 809 HIS LEU VAL GLY ARG TRP ILE ARG THR GLN GLN HIS TYR SEQRES 5 A 809 TYR ASP LYS CYS PRO LYS ARG VAL TYR TYR LEU SER LEU SEQRES 6 A 809 GLU PHE TYR MET GLY ARG THR LEU GLN ASN THR MET ILE SEQRES 7 A 809 ASN LEU GLY LEU GLN ASN ALA CYS ASP GLU ALA ILE TYR SEQRES 8 A 809 GLN LEU GLY LEU ASP ILE GLU GLU LEU GLU GLU ILE GLU SEQRES 9 A 809 GLU ASP ALA GLY LEU GLY ASN GLY GLY LEU GLY ARG LEU SEQRES 10 A 809 ALA ALA CYS PHE LEU ASP SER MET ALA THR LEU GLY LEU SEQRES 11 A 809 ALA ALA TYR GLY TYR GLY ILE ARG TYR GLU TYR GLY ILE SEQRES 12 A 809 PHE ASN GLN LYS ILE ARG ASP GLY TRP GLN VAL GLU GLU SEQRES 13 A 809 ALA ASP ASP TRP LEU ARG TYR GLY ASN PRO TRP GLU LYS SEQRES 14 A 809 SER ARG PRO GLU PHE MET LEU PRO VAL HIS PHE TYR GLY SEQRES 15 A 809 LYS VAL GLU HIS THR ASN THR GLY THR LYS TRP ILE ASP SEQRES 16 A 809 THR GLN VAL VAL LEU ALA LEU PRO TYR ASP THR PRO VAL SEQRES 17 A 809 PRO GLY TYR MET ASN ASN THR VAL ASN THR MET ARG LEU SEQRES 18 A 809 TRP SER ALA ARG ALA PRO ASN ASP PHE ASN LEU ARG ASP SEQRES 19 A 809 PHE ASN VAL GLY ASP TYR ILE GLN ALA VAL LEU ASP ARG SEQRES 20 A 809 ASN LEU ALA GLU ASN ILE SER ARG VAL LEU TYR PRO ASN SEQRES 21 A 809 ASP ASN PHE PHE GLU GLY LYS GLU LEU ARG LEU LYS GLN SEQRES 22 A 809 GLU TYR PHE VAL VAL ALA ALA THR LEU GLN ASP ILE ILE SEQRES 23 A 809 ARG ARG PHE LYS ALA SER LYS PHE GLY SER THR ARG GLY SEQRES 24 A 809 ALA GLY THR VAL PHE ASP ALA PHE PRO ASP GLN VAL ALA SEQRES 25 A 809 ILE GLN LEU ASN ASP THR HIS PRO ALA LEU ALA ILE PRO SEQRES 26 A 809 GLU LEU MET ARG ILE PHE VAL ASP ILE GLU LYS LEU PRO SEQRES 27 A 809 TRP SER LYS ALA TRP GLU LEU THR GLN LYS THR PHE ALA SEQRES 28 A 809 TYR THR ASN HIS THR VAL LEU PRO GLU ALA LEU GLU ARG SEQRES 29 A 809 TRP PRO VAL ASP LEU VAL GLU LYS LEU LEU PRO ARG HIS SEQRES 30 A 809 LEU GLU ILE ILE TYR GLU ILE ASN GLN LYS HIS LEU ASP SEQRES 31 A 809 ARG ILE VAL ALA LEU PHE PRO LYS ASP VAL ASP ARG LEU SEQRES 32 A 809 ARG ARG MET SER LEU ILE GLU GLU GLU GLY SER LYS ARG SEQRES 33 A 809 ILE ASN MET ALA HIS LEU CYS ILE VAL GLY SER HIS ALA SEQRES 34 A 809 VAL ASN GLY VAL ALA LYS ILE HIS SER ASP ILE VAL LYS SEQRES 35 A 809 THR LYS VAL PHE LYS ASP PHE SER GLU LEU GLU PRO ASP SEQRES 36 A 809 LYS PHE GLN ASN LYS THR ASN GLY ILE THR PRO ARG ARG SEQRES 37 A 809 TRP LEU LEU LEU CYS ASN PRO GLY LEU ALA GLU LEU ILE SEQRES 38 A 809 ALA GLU LYS ILE GLY GLU ASP TYR VAL LYS ASP LEU SER SEQRES 39 A 809 GLN LEU THR LYS LEU HIS SER PHE LEU GLY ASP ASP VAL SEQRES 40 A 809 PHE LEU ARG GLU LEU ALA LYS VAL LYS GLN GLU ASN LYS SEQRES 41 A 809 LEU LYS PHE SER GLN PHE LEU GLU THR GLU TYR LYS VAL SEQRES 42 A 809 LYS ILE ASN PRO SER SER MET PHE ASP VAL GLN VAL LYS SEQRES 43 A 809 ARG ILE HIS GLU TYR LYS ARG GLN LEU LEU ASN CYS LEU SEQRES 44 A 809 HIS VAL ILE THR MET TYR ASN ARG ILE LYS LYS ASP PRO SEQRES 45 A 809 LYS LYS LEU PHE VAL PRO ARG THR VAL ILE ILE GLY GLY SEQRES 46 A 809 LYS ALA ALA PRO GLY TYR HIS MET ALA LYS MET ILE ILE SEQRES 47 A 809 LYS LEU ILE THR SER VAL ALA ASP VAL VAL ASN ASN ASP SEQRES 48 A 809 PRO MET VAL GLY SER LYS LEU LYS VAL ILE PHE LEU GLU SEQRES 49 A 809 ASN TYR ARG VAL SER LEU ALA GLU LYS VAL ILE PRO ALA SEQRES 50 A 809 THR ASP LEU SER GLU GLN ILE SER THR ALA GLY THR GLU SEQRES 51 A 809 ALA SER GLY THR GLY ASN MET LYS PHE MET LEU ASN GLY SEQRES 52 A 809 ALA LEU THR ILE GLY THR MET ASP GLY ALA ASN VAL GLU SEQRES 53 A 809 MET ALA GLU GLU ALA GLY GLU GLU ASN LEU PHE ILE PHE SEQRES 54 A 809 GLY MET ARG ILE ASP ASP VAL ALA ALA LEU ASP LYS LYS SEQRES 55 A 809 GLY TYR GLU ALA LYS GLU TYR TYR GLU ALA LEU PRO GLU SEQRES 56 A 809 LEU LYS LEU VAL ILE ASP GLN ILE ASP ASN GLY PHE PHE SEQRES 57 A 809 SER PRO LYS GLN PRO ASP LEU PHE LYS ASP ILE ILE ASN SEQRES 58 A 809 MET LEU PHE TYR HIS ASP ARG PHE LYS VAL PHE ALA ASP SEQRES 59 A 809 TYR GLU ALA TYR VAL LYS CYS GLN ASP LYS VAL SER GLN SEQRES 60 A 809 LEU TYR MET ASN PRO LYS ALA TRP ASN THR MET VAL LEU SEQRES 61 A 809 LYS ASN ILE ALA ALA SER GLY LYS PHE SER SER ASP ARG SEQRES 62 A 809 THR ILE LYS GLU TYR ALA GLN ASN ILE TRP ASN VAL GLU SEQRES 63 A 809 PRO SER ASP SEQRES 1 B 809 ASN VAL ALA GLU LEU LYS LYS SER PHE ASN ARG HIS LEU SEQRES 2 B 809 HIS PHE THR LEU VAL LYS ASP ARG ASN VAL ALA THR THR SEQRES 3 B 809 ARG ASP TYR TYR PHE ALA LEU ALA HIS THR VAL ARG ASP SEQRES 4 B 809 HIS LEU VAL GLY ARG TRP ILE ARG THR GLN GLN HIS TYR SEQRES 5 B 809 TYR ASP LYS CYS PRO LYS ARG VAL TYR TYR LEU SER LEU SEQRES 6 B 809 GLU PHE TYR MET GLY ARG THR LEU GLN ASN THR MET ILE SEQRES 7 B 809 ASN LEU GLY LEU GLN ASN ALA CYS ASP GLU ALA ILE TYR SEQRES 8 B 809 GLN LEU GLY LEU ASP ILE GLU GLU LEU GLU GLU ILE GLU SEQRES 9 B 809 GLU ASP ALA GLY LEU GLY ASN GLY GLY LEU GLY ARG LEU SEQRES 10 B 809 ALA ALA CYS PHE LEU ASP SER MET ALA THR LEU GLY LEU SEQRES 11 B 809 ALA ALA TYR GLY TYR GLY ILE ARG TYR GLU TYR GLY ILE SEQRES 12 B 809 PHE ASN GLN LYS ILE ARG ASP GLY TRP GLN VAL GLU GLU SEQRES 13 B 809 ALA ASP ASP TRP LEU ARG TYR GLY ASN PRO TRP GLU LYS SEQRES 14 B 809 SER ARG PRO GLU PHE MET LEU PRO VAL HIS PHE TYR GLY SEQRES 15 B 809 LYS VAL GLU HIS THR ASN THR GLY THR LYS TRP ILE ASP SEQRES 16 B 809 THR GLN VAL VAL LEU ALA LEU PRO TYR ASP THR PRO VAL SEQRES 17 B 809 PRO GLY TYR MET ASN ASN THR VAL ASN THR MET ARG LEU SEQRES 18 B 809 TRP SER ALA ARG ALA PRO ASN ASP PHE ASN LEU ARG ASP SEQRES 19 B 809 PHE ASN VAL GLY ASP TYR ILE GLN ALA VAL LEU ASP ARG SEQRES 20 B 809 ASN LEU ALA GLU ASN ILE SER ARG VAL LEU TYR PRO ASN SEQRES 21 B 809 ASP ASN PHE PHE GLU GLY LYS GLU LEU ARG LEU LYS GLN SEQRES 22 B 809 GLU TYR PHE VAL VAL ALA ALA THR LEU GLN ASP ILE ILE SEQRES 23 B 809 ARG ARG PHE LYS ALA SER LYS PHE GLY SER THR ARG GLY SEQRES 24 B 809 ALA GLY THR VAL PHE ASP ALA PHE PRO ASP GLN VAL ALA SEQRES 25 B 809 ILE GLN LEU ASN ASP THR HIS PRO ALA LEU ALA ILE PRO SEQRES 26 B 809 GLU LEU MET ARG ILE PHE VAL ASP ILE GLU LYS LEU PRO SEQRES 27 B 809 TRP SER LYS ALA TRP GLU LEU THR GLN LYS THR PHE ALA SEQRES 28 B 809 TYR THR ASN HIS THR VAL LEU PRO GLU ALA LEU GLU ARG SEQRES 29 B 809 TRP PRO VAL ASP LEU VAL GLU LYS LEU LEU PRO ARG HIS SEQRES 30 B 809 LEU GLU ILE ILE TYR GLU ILE ASN GLN LYS HIS LEU ASP SEQRES 31 B 809 ARG ILE VAL ALA LEU PHE PRO LYS ASP VAL ASP ARG LEU SEQRES 32 B 809 ARG ARG MET SER LEU ILE GLU GLU GLU GLY SER LYS ARG SEQRES 33 B 809 ILE ASN MET ALA HIS LEU CYS ILE VAL GLY SER HIS ALA SEQRES 34 B 809 VAL ASN GLY VAL ALA LYS ILE HIS SER ASP ILE VAL LYS SEQRES 35 B 809 THR LYS VAL PHE LYS ASP PHE SER GLU LEU GLU PRO ASP SEQRES 36 B 809 LYS PHE GLN ASN LYS THR ASN GLY ILE THR PRO ARG ARG SEQRES 37 B 809 TRP LEU LEU LEU CYS ASN PRO GLY LEU ALA GLU LEU ILE SEQRES 38 B 809 ALA GLU LYS ILE GLY GLU ASP TYR VAL LYS ASP LEU SER SEQRES 39 B 809 GLN LEU THR LYS LEU HIS SER PHE LEU GLY ASP ASP VAL SEQRES 40 B 809 PHE LEU ARG GLU LEU ALA LYS VAL LYS GLN GLU ASN LYS SEQRES 41 B 809 LEU LYS PHE SER GLN PHE LEU GLU THR GLU TYR LYS VAL SEQRES 42 B 809 LYS ILE ASN PRO SER SER MET PHE ASP VAL GLN VAL LYS SEQRES 43 B 809 ARG ILE HIS GLU TYR LYS ARG GLN LEU LEU ASN CYS LEU SEQRES 44 B 809 HIS VAL ILE THR MET TYR ASN ARG ILE LYS LYS ASP PRO SEQRES 45 B 809 LYS LYS LEU PHE VAL PRO ARG THR VAL ILE ILE GLY GLY SEQRES 46 B 809 LYS ALA ALA PRO GLY TYR HIS MET ALA LYS MET ILE ILE SEQRES 47 B 809 LYS LEU ILE THR SER VAL ALA ASP VAL VAL ASN ASN ASP SEQRES 48 B 809 PRO MET VAL GLY SER LYS LEU LYS VAL ILE PHE LEU GLU SEQRES 49 B 809 ASN TYR ARG VAL SER LEU ALA GLU LYS VAL ILE PRO ALA SEQRES 50 B 809 THR ASP LEU SER GLU GLN ILE SER THR ALA GLY THR GLU SEQRES 51 B 809 ALA SER GLY THR GLY ASN MET LYS PHE MET LEU ASN GLY SEQRES 52 B 809 ALA LEU THR ILE GLY THR MET ASP GLY ALA ASN VAL GLU SEQRES 53 B 809 MET ALA GLU GLU ALA GLY GLU GLU ASN LEU PHE ILE PHE SEQRES 54 B 809 GLY MET ARG ILE ASP ASP VAL ALA ALA LEU ASP LYS LYS SEQRES 55 B 809 GLY TYR GLU ALA LYS GLU TYR TYR GLU ALA LEU PRO GLU SEQRES 56 B 809 LEU LYS LEU VAL ILE ASP GLN ILE ASP ASN GLY PHE PHE SEQRES 57 B 809 SER PRO LYS GLN PRO ASP LEU PHE LYS ASP ILE ILE ASN SEQRES 58 B 809 MET LEU PHE TYR HIS ASP ARG PHE LYS VAL PHE ALA ASP SEQRES 59 B 809 TYR GLU ALA TYR VAL LYS CYS GLN ASP LYS VAL SER GLN SEQRES 60 B 809 LEU TYR MET ASN PRO LYS ALA TRP ASN THR MET VAL LEU SEQRES 61 B 809 LYS ASN ILE ALA ALA SER GLY LYS PHE SER SER ASP ARG SEQRES 62 B 809 THR ILE LYS GLU TYR ALA GLN ASN ILE TRP ASN VAL GLU SEQRES 63 B 809 PRO SER ASP HET NBG A 1 15 HET PO4 A 3 5 HET PLP A 832 16 HET AVE A 833 29 HET NBG B 2 15 HET PO4 B 4 5 HET MES B 1 12 HET PLP B 832 16 HET AVE B 833 29 HETNAM NBG N-ACETYL-BETA-D-GLUCOPYRANOSYLAMINE HETNAM PO4 PHOSPHATE ION HETNAM PLP PYRIDOXAL-5'-PHOSPHATE HETNAM AVE 4-[3-(2-CHLORO-4,5-DIFLUORO-BENZOYL)UREIDO]-3- HETNAM 2 AVE TRIFLUOROMETHOXYBENZOIC ACID HETNAM MES 2-(N-MORPHOLINO)-ETHANESULFONIC ACID HETSYN PLP VITAMIN B6 PHOSPHATE HETSYN AVE 4-({[(2-CHLORO-4,5-DIFLUOROPHENYL) HETSYN 2 AVE CARBONYL]CARBAMOYL}AMINO)-3-(TRIFLUOROMETHOXY)BENZOIC HETSYN 3 AVE ACID FORMUL 3 NBG 2(C8 H15 N O6) FORMUL 4 PO4 2(O4 P 3-) FORMUL 5 PLP 2(C8 H10 N O6 P) FORMUL 6 AVE 2(C16 H8 CL F5 N2 O5) FORMUL 9 MES C6 H13 N O4 S FORMUL 12 HOH *508(H2 O) HELIX 1 1 ASN A 23 THR A 38 1 16 HELIX 2 2 ASP A 42 ALA A 46 5 5 HELIX 3 3 THR A 47 CYS A 78 1 32 HELIX 4 4 THR A 94 LEU A 102 1 9 HELIX 5 5 LEU A 104 LEU A 115 1 12 HELIX 6 6 ASP A 118 GLU A 126 1 9 HELIX 7 7 GLY A 134 LEU A 150 1 17 HELIX 8 8 PRO A 194 MET A 197 5 4 HELIX 9 9 ASP A 261 ASP A 268 1 8 HELIX 10 10 ASP A 268 ASN A 274 1 7 HELIX 11 11 ILE A 275 ARG A 277 5 3 HELIX 12 12 LYS A 289 SER A 314 1 26 HELIX 13 13 ALA A 328 GLN A 332 1 5 HELIX 14 14 LEU A 344 ILE A 356 1 13 HELIX 15 15 PRO A 360 THR A 371 1 12 HELIX 16 16 LEU A 380 LEU A 384 5 5 HELIX 17 17 VAL A 389 LEU A 396 1 8 HELIX 18 18 LEU A 396 ALA A 416 1 21 HELIX 19 19 ASP A 421 SER A 429 1 9 HELIX 20 20 MET A 441 GLY A 448 1 8 HELIX 21 21 ALA A 456 LYS A 466 1 11 HELIX 22 22 PHE A 468 GLU A 473 1 6 HELIX 23 23 GLU A 475 ASP A 477 5 3 HELIX 24 24 ASN A 496 GLY A 508 1 13 HELIX 25 25 GLU A 509 LYS A 513 5 5 HELIX 26 26 ASP A 514 GLY A 526 5 13 HELIX 27 27 ASP A 527 THR A 551 1 25 HELIX 28 28 ARG A 575 LYS A 592 1 18 HELIX 29 29 TYR A 613 ASN A 631 1 19 HELIX 30 30 ARG A 649 ILE A 657 1 9 HELIX 31 31 PRO A 658 THR A 660 5 3 HELIX 32 32 THR A 676 ASN A 684 1 9 HELIX 33 33 ASP A 693 GLY A 704 1 12 HELIX 34 34 GLU A 705 LEU A 708 5 4 HELIX 35 35 ARG A 714 GLY A 725 1 12 HELIX 36 36 ALA A 728 LEU A 735 1 8 HELIX 37 37 LEU A 735 GLY A 748 1 14 HELIX 38 38 PHE A 758 HIS A 768 1 11 HELIX 39 39 VAL A 773 ALA A 775 5 3 HELIX 40 40 ASP A 776 MET A 792 1 17 HELIX 41 41 ASN A 793 ALA A 806 1 14 HELIX 42 42 ALA A 807 PHE A 811 5 5 HELIX 43 43 SER A 812 ILE A 824 1 13 HELIX 44 44 ASN B 23 THR B 38 1 16 HELIX 45 45 ASP B 42 ALA B 46 5 5 HELIX 46 46 THR B 47 HIS B 62 1 16 HELIX 47 47 LEU B 63 CYS B 78 1 16 HELIX 48 48 THR B 94 LEU B 102 1 9 HELIX 49 49 LEU B 104 LEU B 115 1 12 HELIX 50 50 ASP B 118 GLU B 126 1 9 HELIX 51 51 GLY B 134 LEU B 150 1 17 HELIX 52 52 PRO B 194 MET B 197 5 4 HELIX 53 53 ASP B 261 ARG B 269 1 9 HELIX 54 54 ARG B 269 ASN B 274 1 6 HELIX 55 55 LYS B 289 ALA B 313 1 25 HELIX 56 56 THR B 324 ASP B 327 5 4 HELIX 57 57 ALA B 328 GLN B 332 1 5 HELIX 58 58 LEU B 344 ILE B 356 1 13 HELIX 59 59 PRO B 360 THR B 371 1 12 HELIX 60 60 LEU B 380 LEU B 384 5 5 HELIX 61 61 VAL B 389 LEU B 396 1 8 HELIX 62 62 LEU B 396 PHE B 418 1 23 HELIX 63 63 ASP B 421 SER B 429 1 9 HELIX 64 64 MET B 441 SER B 449 1 9 HELIX 65 65 ALA B 456 LYS B 466 1 11 HELIX 66 66 PHE B 468 GLU B 475 1 8 HELIX 67 67 ASN B 496 GLY B 508 1 13 HELIX 68 68 GLU B 509 LYS B 513 5 5 HELIX 69 69 ASP B 514 LEU B 525 5 12 HELIX 70 70 ASP B 527 TYR B 553 1 27 HELIX 71 71 ARG B 575 ASP B 593 1 19 HELIX 72 72 TYR B 613 ASP B 633 1 21 HELIX 73 73 VAL B 636 SER B 638 5 3 HELIX 74 74 ARG B 649 ILE B 657 1 9 HELIX 75 75 PRO B 658 THR B 660 5 3 HELIX 76 76 THR B 676 ASN B 684 1 9 HELIX 77 77 ALA B 695 GLY B 704 1 10 HELIX 78 78 GLU B 705 LEU B 708 5 4 HELIX 79 79 ARG B 714 GLY B 725 1 12 HELIX 80 80 GLU B 727 LEU B 735 1 9 HELIX 81 81 LEU B 735 ASN B 747 1 13 HELIX 82 82 PHE B 758 HIS B 768 1 11 HELIX 83 83 LYS B 772 MET B 792 1 21 HELIX 84 84 ASN B 793 ALA B 806 1 14 HELIX 85 85 ALA B 807 PHE B 811 5 5 HELIX 86 86 SER B 812 ILE B 824 1 13 SHEET 1 A 3 LYS A 191 SER A 192 0 SHEET 2 A 3 GLN A 219 PRO A 231 -1 O ASP A 227 N LYS A 191 SHEET 3 A 3 LEU A 198 PHE A 202 -1 N VAL A 200 O VAL A 221 SHEET 1 B 9 LYS A 191 SER A 192 0 SHEET 2 B 9 GLN A 219 PRO A 231 -1 O ASP A 227 N LYS A 191 SHEET 3 B 9 VAL A 238 ARG A 247 -1 O ARG A 247 N LEU A 222 SHEET 4 B 9 ALA A 154 ILE A 159 1 N GLY A 156 O ARG A 242 SHEET 5 B 9 ARG A 81 LEU A 85 1 N TYR A 84 O TYR A 155 SHEET 6 B 9 VAL A 333 ASN A 338 1 O ALA A 334 N ARG A 81 SHEET 7 B 9 PHE A 372 THR A 375 1 O ALA A 373 N LEU A 337 SHEET 8 B 9 ALA A 451 GLY A 454 1 O ALA A 451 N TYR A 374 SHEET 9 B 9 PHE A 479 ASN A 481 1 O GLN A 480 N VAL A 452 SHEET 1 C 2 PHE A 89 GLY A 92 0 SHEET 2 C 2 ALA A 129 LEU A 131 -1 O LEU A 131 N PHE A 89 SHEET 1 D 2 ASN A 167 ARG A 171 0 SHEET 2 D 2 TRP A 174 GLU A 178 -1 O VAL A 176 N LYS A 169 SHEET 1 E 2 LYS A 205 THR A 209 0 SHEET 2 E 2 GLY A 212 ILE A 216 -1 O LYS A 214 N GLU A 207 SHEET 1 F 3 ARG A 386 PRO A 388 0 SHEET 2 F 3 ARG A 438 ASN A 440 -1 O ILE A 439 N TRP A 387 SHEET 3 F 3 ILE A 431 GLU A 432 -1 N GLU A 432 O ARG A 438 SHEET 1 G 6 LEU A 640 LEU A 645 0 SHEET 2 G 6 ARG A 601 GLY A 606 1 N VAL A 603 O ILE A 643 SHEET 3 G 6 MET A 562 VAL A 567 1 N ASP A 564 O THR A 602 SHEET 4 G 6 LEU A 662 GLN A 665 1 O LEU A 662 N PHE A 563 SHEET 5 G 6 LEU A 687 GLY A 690 1 O ILE A 689 N GLN A 665 SHEET 6 G 6 PHE A 709 ILE A 710 1 O PHE A 709 N THR A 688 SHEET 1 H 3 LYS B 191 SER B 192 0 SHEET 2 H 3 GLN B 219 PRO B 231 -1 O ASP B 227 N LYS B 191 SHEET 3 H 3 LEU B 198 PHE B 202 -1 N PHE B 202 O GLN B 219 SHEET 1 I 9 LYS B 191 SER B 192 0 SHEET 2 I 9 GLN B 219 PRO B 231 -1 O ASP B 227 N LYS B 191 SHEET 3 I 9 VAL B 238 ARG B 247 -1 O ARG B 247 N LEU B 222 SHEET 4 I 9 ALA B 154 ILE B 159 1 N GLY B 156 O ARG B 242 SHEET 5 I 9 ARG B 81 LEU B 85 1 N VAL B 82 O TYR B 155 SHEET 6 I 9 VAL B 333 ASN B 338 1 O ALA B 334 N TYR B 83 SHEET 7 I 9 PHE B 372 THR B 375 1 O ALA B 373 N LEU B 337 SHEET 8 I 9 ALA B 451 GLY B 454 1 O ALA B 451 N TYR B 374 SHEET 9 I 9 PHE B 479 ASN B 481 1 O GLN B 480 N VAL B 452 SHEET 1 J 2 PHE B 89 TYR B 90 0 SHEET 2 J 2 GLY B 130 LEU B 131 -1 O LEU B 131 N PHE B 89 SHEET 1 K 2 ASN B 167 ILE B 170 0 SHEET 2 K 2 GLN B 175 GLU B 178 -1 O VAL B 176 N LYS B 169 SHEET 1 L 2 LYS B 205 THR B 209 0 SHEET 2 L 2 GLY B 212 ILE B 216 -1 O LYS B 214 N GLU B 207 SHEET 1 M 3 ARG B 386 PRO B 388 0 SHEET 2 M 3 ARG B 438 ASN B 440 -1 O ILE B 439 N TRP B 387 SHEET 3 M 3 ILE B 431 GLU B 432 -1 N GLU B 432 O ARG B 438 SHEET 1 N 6 LEU B 640 LEU B 645 0 SHEET 2 N 6 ARG B 601 GLY B 606 1 N ILE B 605 O LEU B 645 SHEET 3 N 6 MET B 562 VAL B 567 1 N GLN B 566 O ILE B 604 SHEET 4 N 6 LEU B 662 GLN B 665 1 O LEU B 662 N VAL B 565 SHEET 5 N 6 LEU B 687 GLY B 690 1 O LEU B 687 N SER B 663 SHEET 6 N 6 PHE B 709 ILE B 710 1 O PHE B 709 N THR B 688 LINK NZ LYS A 680 C4A PLP A 832 1555 1555 1.61 LINK NZ LYS B 680 C4A PLP B 832 1555 1555 1.45 CRYST1 124.115 124.115 122.491 90.00 90.00 120.00 P 31 6 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.008057 0.004652 0.000000 0.00000 SCALE2 0.000000 0.009303 0.000000 0.00000 SCALE3 0.000000 0.000000 0.008164 0.00000